Wheelchair was Jin Medical International’s largest product and service line in fiscal 2021, bringing in $18.21M of $20.76M (88%).
| Product and Service | FY 2021 |
|---|---|
| Wheelchair | $18.21M |
| Wheelchair Components & Others | $2.56M |
| Total | $20.76M |
Jin Medical International brought in $20.76M from its two product and service lines in fiscal 2021, the year ended September 30, 2021. Wheelchair was the largest at $18.21M (87.7%), ahead of Wheelchair Components & Others at $2.56M (12.3%).
Overseas Market was Jin Medical International’s largest region in fiscal 2021, bringing in $18.22M of $20.76M (88%).
| Geography | FY 2021 |
|---|---|
| Overseas Market | $18.22M |
| China Domestic Market | $2.55M |
| Total | $20.76M |
Jin Medical International brought in $20.76M from its two regions in fiscal 2021, the year ended September 30, 2021. Overseas Market was the largest at $18.22M (87.7%), ahead of China Domestic Market at $2.55M (12.3%).
Jin Medical International (ZJYL) reports its revenue by product and service and by geography. In fiscal 2021, Wheelchair was its largest product and service line, bringing in $18.21M (87.7% of the total), followed by Wheelchair Components & Others at $2.56M (12.3%).
Wheelchair was Jin Medical International's largest product and service line in fiscal 2021, bringing in $18.21M, or 87.7% of the $20.76M total across its two product and service lines.
Overseas Market was Jin Medical International's largest region in fiscal 2021, bringing in $18.22M, or 87.7% of the $20.76M total across its two regions.
Every figure comes from Jin Medical International's annual financial filings, as reported. Each line keeps the name Jin Medical International gives it, and years follow its fiscal calendar.
Jin Medical International's revenue by product and service goes back to fiscal 2021, with figures through fiscal 2021. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.